INTERNATIONAL PATENT: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES FILES APPLICATION FOR "ENHANCED TUMOR REACTIVITY OF T CELLS LACKING SIT1, LAX1, OR TRAT1"

GENEVA, Aug. 6 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Office of Technology TransferNational Institutes of Health6701 Rockledge Drive, Suite 700, MSC 7788Bethesda, MD 20892-7788) filed a patent application (PCT/US2025/013054) for "ENHANCED TUMOR REACTIVITY OF T CELLS LACKING SIT1, LAX1, OR TRAT1" on Jan 24, 2025. With publication no. WO/2025/160480, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LOVE, Paul, E. (18101 Old Baltimore RoadOlney, MD 20832), DU...